About Immunix
Immunix was established in 1998 in Portland, United States, within the software security sector. Focus has been placed on enhancing operating systems, particularly Linux variants, for improved protection against vulnerabilities. Services include development of security tools and hardened distributions. Operations remain centered in the US under CEO Cheryl Traverse, though detailed current activities are sparsely documented.
- Headquarter Portland, United States
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Immunix
Detailed funding history for Immunix
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Immunix
Immunix has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Novell.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Enterprise software solutions for productivity and security are delivered.
|
Locked | Locked | Locked |
Investor details for Immunix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Immunix
Investment portfolio details for Immunix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Immunix
Detailed financials for Immunix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Immunix Comparisons
Peer comparison for Immunix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Immunix
Detailed competitors of Immunix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Immunix
Complete news archive for Immunix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Immunix
Immunix was founded in 1998.
Immunix is headquartered in Portland, United States. It is registered at Portland, Oregon, United States.
Cheryl Traverse is the current CEO of Immunix.
Immunix was established in 1998 in Portland, United States, within the software security sector. Focus has been placed on enhancing operating systems, particularly Linux variants, for improved protection against vulnerabilities. Services include development of security tools and hardened distributions. Operations remain centered in the US under CEO Cheryl Traverse, though detailed current activities are sparsely documented.
Immunix has 1 investor. Key investors include Novell.